| 序号 | CAS | 产品名称 | 规格 | 包装 |
参考价格 |
| 1 | 99120-49-7 | GLP-2(1-34)(human) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 2 | 38579-21-4 | H-Ile-Tyr-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 3 | 13589-06-5 | H-Ile-Trp-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 4 | 22951-98-0 | H-Ile-Phe-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 5 | 26462-22-6 | H-Ile-Leu-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 6 | 42537-99-5 | H-Ile-Ile-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 7 | 42516-53-0 | H-Ile-Glu-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 8 | 24787-73-3 | H-ILE-ALA-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 9 | 40216-83-9 | H-Hyp-Ome·HCl |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 10 | 35979-00-1 | H-His-Tyr-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 11 | 21438-60-8 | H-His-Ser-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 12 | 16874-81-0 | H-His-Phe-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 13 | 151151-29-0 | H-His-Lys-OH·HBr |
≥98% | | 询价 |
| 14 | 158561-91-2 | H-HIS-HIS-GLY-VAL-VAL-GLU-VAL-ASP-ALA-ALA-VAL-THR-PRO-GLU-GLU-ARG-HIS-LEU-SER-LYS-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 15 | 2578-58-7 | H-His-Gly-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 16 | 41658-60-0 | H-His-Asp-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 17 | 19461-37-1 | H-Gly-γ-Abu-OH |
≥98% | | 询价 |
| 18 | 3695-73-6 | H-Gly-β-Ala-OH |
≥98% | | 询价 |
| 19 | 16422-05-2 | H-Gly-β-Ala-Gly-OH |
≥98% | | 询价 |
| 20 | 15761-60-1 | H-Gly-Tyr-NH2 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 21 | 23067-32-5 | H-GLY-TRP-GLY-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 22 | 13100-15-7 | H-Gly-Pro-Pro-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 23 | 141497-12-3 | H-Gly-Pro-Gly-NH2·HCl |
≥98% | | 询价 |
| 24 | 13054-03-0 | H-Gly-Pro-Gly-Gly-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 25 | 126047-84-5 | H-Gly-Pro-Arg-Pro-Pro-NH2 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 26 | 934343-74-5 | NVP-HSP990 |
| 5mg, 10mg, 50mg | 询价 |
| 27 | 301356-95-6 | CID5721353 |
≥98% | | 询价 |
| 28 | 1219184-91-4 | CCT-031374 hydrobromide |
≥98% | | 询价 |
| 29 | 1044511-01-4 | Benralizumab(MEDI-563) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 30 | 150812-12-7 | Retigabine |
| 5mg, 10mg, 50mg, 100mg | 询价 |
| 31 | 76974-79-3 | GR-24 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 32 | 1010100-22-7 | Thalidomide-5-CH2-NH2 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 33 | 686773-12-6 | ZK-994 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 34 | 2173387-57-8 | AGH-192 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 35 | 1431884-83-1 | MPK-09 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 36 | 1449566-36-2 | RS-09 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 37 | 356776-32-4 | AG-09/1 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 38 | 2556836-50-9 | DGY-06-116 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 39 | 1609389-52-7 | ACY-957 |
≥98% | | 询价 |
| 40 | 865466-24-6 | Narlaprevir |
≥98% | | 询价 |
| 41 | 214766-78-6 | Degarelix |
≥98% | | 询价 |
| 42 | 1448297-52-6 | PROTAC-VHL-ligand |
≥98% | | 询价 |
| 43 | 98636-73-8 | Nitrocaramiphen hydrochloride |
≥98% | | 询价 |
| 44 | 862832-38-0 | CC-401 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 45 | 29560-24-5 | 24(28)-Dehydroergosterol |
≥98% | | 询价 |
| 46 | 148672-13-3 | GR-127935 |
≥98% | | 询价 |
| 47 | 55648-20-9 | Alprostadil alfadex |
≥98% | | 询价 |
| 48 | 126602-89-9 | Quinupristin-dalfopristin |
≥98% | | 询价 |
| 49 | 2479276-17-8 | AXC-715 trihydrochloride |
≥98% | | 询价 |
| 50 | 187400-85-7 | ER-50891 |
≥98% | | 询价 |
| 51 | 92309-29-0 | Imipenem-Cilastatin sodium hydrate |
≥98% | | 询价 |
| 52 | 2132990-98-6 | FABP5-IN-1 |
≥98% | | 询价 |
| 53 | 220524-71-0 | Green DND-26 |
≥98% | | 询价 |
| 54 | 1219810-13-5 | 1R,3S-RSL 3 |
≥98% | | 询价 |
| 55 | 304694-39-1 | sb-435495 |
≥98% | | 询价 |
| 56 | 1051375-13-3 | Cabotegravir sodium |
≥98% | | 询价 |
| 57 | 1779569-15-1 | CX-201 |
≥98% | | 询价 |
| 58 | 1471484-62-4 | YH-53 |
≥98% | | 询价 |
| 59 | 187277-46-9 | rac-Irofulven |
≥98% | | 询价 |
| 60 | 2504913-62-4 | ARV-766 |
≥98% | | 询价 |
m.cnreagent.com